This is a multicenter, prospective, observational, post-market clinical follow-up (PMCF) study designed to evaluate the safety and clinical performance of the Tipmed™ Revision Hip Prosthesis System in adult participants undergoing revision hip arthroplasty. The study aims to gather real-world clinical evidence on the 24-month post-operative safety profile, potential complications, and functional outcomes of the device during routine clinical practice.
Individuals aged 18 years and older,
Male or female participants,
Participants who have undergone Revision Hip Arthroplasty (either total revision or partial component revision) for any indication (such as a documented joint failure or prosthesis-related clinical complication),
Participants in whose revision procedure the Tıpmed™ Revision Hip Prosthesis System components were utilized,
Subjects currently participating in any other interventional clinical trial.
TIPMED Medical Device Manufacturing Ltd. Co.
Lead sponsor